| Serial Number | 98576548 |
| Word Mark | CONVERGENCE BIO |
| Filing Date | Thursday, May 30, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, July 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, vaccines, \ medical therapeutics, and medical therapeutic pharmaceuticals for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; vaccines for human use; pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; nutritional and dietary supplements for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss |
| Goods and Services | research and development services in the field of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development services of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; research and development of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic modalities for treatment of aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; development of pharmaceutical preparations, vaccines and medicines; medical research for development of therapeutic modalities for treatment of diseases; pharmaceutical, vaccine, medical therapeutic, and medical therapeutic pharmaceutical drug development and discovery; assays and reagents for use in scientific and biomedical research; clinical studies; preclinical and clinical development of therapeutic products, namely, development of medicines, pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Convergence Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02199 |
| Event Date | Event Description |
| Thursday, May 30, 2024 | NEW APPLICATION ENTERED |
| Wednesday, August 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 2, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 12, 2024 | ASSIGNED TO EXAMINER |
| Thursday, January 2, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, January 2, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 5, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, July 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 2, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 2, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 2, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, July 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 5, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |